To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 96 shares, the number of shares held increased 0.24% compared to the previous period and now represents 0.72% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 134,639 shares, the number of shares held increased 1.28% compared to the previous period and now represents 1.59% of the total position.
      5.28KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 1,666 shares, the number of shares held increased 0.25% compared to the previous period and now represents 5.59% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 3,804 shares, the number of shares held increased 0.25% compared to the previous period and now represents 2.44% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 442 shares, the number of shares held increased 0.25% compared to the previous period and now represents 2.06% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 62 shares, the number of shares held increased 0.25% compared to the previous period and now represents 0.95% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 29,038 shares, the number of shares held increased 0.25% compared to the previous period and now represents 4.23% of the total position.
      48Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 8,242 shares, the number of shares held increased 0.38% compared to the previous period and now represents 4.95% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Veracyte by 2,622 shares, the number of shares held increased 0.25% compared to the previous period and now represents 3.74% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 25,526 shares, the number of shares held increased 0.84% compared to the previous period and now represents 2.42% of the total position.
      2Comment
      Report
       
       
       
       

      Most Discussed